Cover Image
市場調查報告書

美國的靜脈通路裝置、配件市場上治療數量

US Procedure Numbers for Vascular Access Devices and Accessories 2016 - MedPro

出版商 iData Research Inc. 商品編碼 360589
出版日期 內容資訊 英文 148 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的靜脈通路裝置、配件市場上治療數量 US Procedure Numbers for Vascular Access Devices and Accessories 2016 - MedPro
出版日期: 2016年05月01日 內容資訊: 英文 148 Pages
簡介

美國的靜脈通路裝置、配件市場,2015年增大。今後,也預計繼續成長。

本報告提供美國的靜脈通路裝置、配件市場上治療數量調查分析,疾病概要,血管通路治療數量相關的系統性資訊。

第1章 摘要整理

第2章 調查手法

第3章 疾病概要

  • 基本結構
  • 血管病變、障礙
  • 患者的人口統計
    • 癌症
    • 末期腎功能衰竭
    • 糖尿病

第4章 血管通路治療數量

  • 治療行為編碼
  • 血管通路治療全體
  • 置入式埠口
  • Port Needle
  • 中央靜脈導管 (CVC)
  • 週邊置入中央靜脈導管 (PICC)
  • 週邊靜脈導管 (PIVC)
  • 透析用導管
  • 超音波血管通路治療

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: iDATA_USVA16_MP

The U.S. market for vascular access devices and accessories includes implantable ports, port needles, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), peripheral intravenous catheters (PIVCs), midlines, dialysis catheters, ultrasound machines, tip guidance devices, catheter securement devices, syringes and needles.

Segments Covered in this Procedure Volume Research

This market study focuses specifically on the volume of procedures. It includes analysis of procedures.

This data outlines the exact growth rates for procedures. If you're interested in seeing the trends in procedures to formulate your market sizing and forecasts this is the most accurate and most affordable way to do it.

About Procedure Volume Research (MedPro)

Our analysts meticulously research for 3 to 4 months to put together a suite of reports, which is a comprehensive analysis on a group of healthcare markets. A MedPro is one portion of that analysis that outlines only the procedure volumes and forecasts for each market in that suite of reports.

This procedural analysis is incorporated in our market size analysis and forecasting which are available when purchasing a MedSuite, MedView or MedCore.

Where Do We Get Our Procedure Data?

Our team of analysts has proprietary data that we've been collecting for over a decade as well as government and private databases like that from CMS and hospital records. By looking at multiple sources we are able to triangulate on orthopedic soft tissue procedure volumes that influence and coincide with our overall market sizing.

Questions This Report will Help You Answer:

What is affecting the volume of procedures?

How many procedures were done in 2016?

How many procedures were done historically?

How many procedures can we expect in 2023 and what is the growth trend?

TABLE OF CONTENTS ............................................................................................................... I

LIST OF FIGURES.................................................................................................................... IV

LIST OF CHARTS ................................................................................................................... VII

EXECUTIVE SUMMARY

  • 1.1 U.S. VASCULAR ACCESS DEVICES AND ACCESSORIES MARKET OVERVIEW
  • 1.2 COMPETITIVE LANDSCAPE
  • 1.3 MARKET TRENDS
  • 1.4 KEY MARKET DEVELOPMENTS
  • 1.5 MARKETS INCLUDED
  • 1.6 PROCEDURES INCLUDED
  • 1.7 PROCEDURE CODES INVESTIGATED
  • 1.8 KEY REPORT UPDATES
  • 1.9 VERSION HISTORY

RESEARCH METHODOLOGY

  • 2.1 RESEARCH SCOPE
  • 2.2 IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring..................................................................... 27 DISEASE OVERVIEW
  • 3.1 BASIC ANATOMY
    • 3.1.1 Human Vascular System
  • 3.2 VASCULAR PATHOLOGY AND DISORDERS
    • 3.2.1 Cancer
    • 3.2.2 End-Stage Renal Disease
    • 3.2.3 Diabetes
  • 3.3 PATIENT DEMOGRAPHICS
    • 3.3.1 Cancer
      • 3.3.1.1 Digestive Cancer
      • 3.3.1.2 Genital Cancer
      • 3.3.1.3 Breast Cancer
      • 3.3.1.4 Respiratory Cancer
      • 3.3.1.5 Urinary Cancer
      • 3.3.1.6 Skin Cancer
      • 3.3.1.7 Lymphoma
      • 3.3.1.8 Endocrine System Cancer
      • 3.3.1.9 Leukemia
      • 3.3.1.10 Oral Cavity/Larynx
      • 3.3.1.11 Myeloma
      • 3.3.1.12 Brain/Other Nervous System
      • 3.3.1.13 Soft Tissue (including heart)
      • 3.3.1.14 Bones and Joints
      • 3.3.1.15 Eye and Orbit
    • 3.3.2 End-Stage Renal Disease
      • 3.3.2.1 End-Stage Renal Disease Incidence
      • 3.3.2.1.1 End-Stage Renal Disease Incident Cases by Modality
      • 3.3.2.1.2 End-Stage Renal Disease Incident Cases by Age Group
      • 3.3.2.1.3 End-Stage Renal Disease Incident Cases Using Home Dialysis by Therapy
      • 3.3.2.2 Vascular Access Use at Hemodialysis Initiation
      • 3.3.2.2.1 Vascular Access Use During First Year of Hemodialysis

3.3.2.2.1.1 Vascular Access Use During First Year of Hemodialysis by Age Group............................ 87 3.3.2.2.1.2 Vascular Access Use During First Year of Hemodialysis by Sex

End-3.3.2.3 Stage Renal Disease Prevalence

      • 3.3.2.3.1 End-Stage Renal Disease Prevalent Cases by Modality

3.3.2.3.1.1 Prevalent Hemodialysis Patients by Vascular Access Type

      • 3.3.2.3.2 End-Stage Renal Disease Prevalent Cases by Age Group
      • 3.3.2.3.3 End-Stage Renal Disease Prevalent Cases Using Home Dialysis by Therapy
    • 3.3.3 Diabetes
      • 3.3.3.1 Diagnosed Diabetes Incidence Amongst Adults
      • 3.3.3.1.1 Diagnosed Diabetes Incidence Amongst Adults by State
      • 3.3.3.2 Diagnosed Diabetes Prevalence Amongst Adults
      • 3.3.3.2.1 Diagnosed Diabetes Prevalence Amongst Adults by Medication Status
      • 3.3.3.2.2 Diagnosed Diabetes Prevalence Amongst Adults by State and Age Group
      • 3.3.3.2.3 Diagnosed Diabetes Prevalence Amongst Adults by State and Gender

VASCULAR ACCESS PROCEDURE NUMBERS

  • 4.1 PROCEDURE CODES INVESTIGATED
  • 4.2 OVERALL VASCULAR ACCESS PROCEDURES
  • 4.3 IMPLANTABLE PORT PROCEDURES
  • 4.4 PORT NEEDLE PROCEDURES
  • 4.5 CVC PROCEDURES
  • 4.6 PICC PROCEDURES
  • 4.7 PIVC PROCEDURES
  • 4.8 DIALYSIS CATHETER PROCEDURES
  • 4.9 ULTRASOUND VASCULAR ACCESS PROCEDURES

LIST OF CHARTS

LIST OF CHARTS

  • Chart 0-1: Vascular Access Device Market by Segment, U.S., 2012 - 2022
  • Chart 0-2: Vascular Access Device Market Overview, U.S., 2015 and 2022
  • Chart 3-1: Male Incidence, Digestive Cancer, U.S., 2016
  • Chart 3-2: Male Deaths, Digestive Cancer, U.S., 2016
  • Chart 3-3: Female Incidence, Digestive Cancer, U.S., 2016
  • Chart 3-4: Female Deaths, Digestive Cancer, U.S., 2016
  • Chart 3-5: Male Incidence, Genital Cancer, U.S., 2016
  • Chart 3-6: Male Deaths, Genital Cancer, U.S., 2016
  • Chart 3-7: Female Incidence, Genital Cancer, U.S., 2016
  • Chart 3-8: Female Deaths, Genital Cancer, U.S., 2016
  • Chart 3-9: Incidence by Gender, Breast Cancer, U.S., 2016
  • Chart 3-10: Deaths by Gender, Breast Cancer, U.S., 2016
  • Chart 3-11: Male Incidence, Respiratory Cancer, U.S., 2016
  • Chart 3-12: Male Deaths, Respiratory Cancer, U.S., 2016
  • Chart 3-13: Female Incidence, Respiratory Cancer, U.S., 2016
  • Chart 3-14: Female Deaths, Respiratory Cancer, U.S., 2016
  • Chart 3-15: Male Incidence, Urinary Cancer, U.S., 2016
  • Chart 3-16: Male Deaths, Urinary Cancer, U.S., 2016
  • Chart 3-17: Female Incidence, Urinary Cancer, U.S., 2016
  • Chart 3-18: Female Deaths, Urinary Cancer, U.S., 2016
  • Chart 3-19: Male Incidence, Skin Cancer, U.S., 2016
  • Chart 3-20: Male Deaths, Skin Cancer, U.S., 2016
  • Chart 3-21: Female Incidence, Skin Cancer, U.S., 2016
  • Chart 3-22: Female Deaths, Skin Cancer, U.S., 2016
  • Chart 3-23: Male Incidence, Lymphoma Cancer, U.S., 2016
  • Chart 3-24: Male Deaths, Lymphoma Cancer, U.S., 2016
  • Chart 3-25: Female Incidence, Lymphoma Cancer, U.S., 2016
  • Chart 3-26: Female Deaths, Lymphoma Cancer, U.S., 2016
  • Chart 3-27: Male Incidence, Endocrine Cancer, U.S., 2016 ......................................................................... 57 Chart 3-28: Male Deaths, Endocrine Cancer, U.S., 2016
  • Chart 3-29: Female Incidence, Endocrine Cancer, U.S., 2016
  • Chart 3-30: Female Deaths, Endocrine Cancer, U.S., 2016
  • Chart 3-31: Male Incidence, Leukemia Cancer, U.S., 2016
  • Chart 3-32: Male Deaths, Leukemia Cancer, U.S., 2016
  • Chart 3-33: Female Incidence, Leukemia Cancer, U.S., 2016
  • Chart 3-34: Female Deaths, Leukemia Cancer, U.S., 2016
  • Chart 3-35: Male Incidence, Oral Cavity/Larynx Cancer, U.S., 2016
  • Chart 3-36: Male Deaths, Oral Cavity/Larynx Cancer, U.S., 2016
  • Chart 3-37: Female Incidence, Oral Cavity/Larynx Cancer, U.S., 2016
  • Chart 3-38: Female Deaths, Oral Cavity/Larynx Cancer, U.S., 2016
  • Chart 3-39: Incidence by Gender, Myeloma Cancer, U.S., 2016
  • Chart 3-40: Deaths by Gender, Myeloma Cancer, U.S., 2016
  • Chart 3-41: Incidence by Gender, Brain/Other Nervous System Cancer, U.S., 2016
  • Chart 3-42: Deaths by Gender, Brain/Other Nervous System Cancer, U.S., 2016
  • Chart 3-43: Incidence by Gender, Soft Tissue Cancer, U.S., 2016
  • Chart 3-44: Deaths by Gender, Soft Tissue Cancer, U.S., 2016
  • Chart 3-45: Incidence by Gender, Bone and Joint Cancers, U.S., 2016
  • Chart 3-46: Deaths by Gender, Bone and Joint Cancers, U.S., 2016
  • Chart 3-47: Incidence by Gender, Eye and Orbit Cancers, U.S., 2016
  • Chart 3-48: Deaths by Gender, Eye and Orbit Cancers, U.S., 2016
  • Chart 3-49: End-Stage Renal Disease Incident Cases, U.S., 1996 - 2015
  • Chart 3-50: End-Stage Renal Disease Incident Cases by Modality, U.S., 1996 - 2015
  • Chart 3-51: End-Stage Renal Disease Incident Cases by Age Group, U.S., 1996 - 2015
  • Chart 3-52: End-Stage Renal Disease Incident Cases Using Home Dialysis by Therapy, U.S., 1996 - 2015 83
  • Chart 3-53: Vascular Access Use at Hemodialysis Initiation, U.S., 2005 - 2015
  • Chart 3-54: Vascular Access Use During First Year of Hemodialysis, U.S., 2013 - 2014
  • Chart 3-55: End-Stage Renal Disease Prevalent Case Count, U.S., 1996 - 2015
  • Chart 3-56: End-Stage Renal Disease Prevalent Cases by Modality, U.S., 1996 - 2015
  • Chart 3-57: Prevalent Hemodialysis Patients by Vascular Access Type, U.S., 2003 - 2015
  • Chart 3-58: End-Stage Renal Disease Prevalent Cases by Age Group, U.S., 1996 - 2015
  • Chart 3-59: End-Stage Renal Disease Prevalent Cases Using Home Dialysis by Therapy, U.S., 1996 - 2015

  • Chart 3-60: Diagnosed Diabetes Incidence Count Adults, U.S., 1997 - 2015 ........................................... 102 Chart 3-61: Diagnosed Diabetes Prevalence Count Adults, U.S., 1997 - 2015
  • Chart 4-1: Overall Vascular Access Procedures, U.S., 2012 - 2022
  • Chart 4-2: Implantable Port Insertion Procedures, U.S., 2012 - 2022
  • Chart 4-3: Port Needle Insertion Procedures, U.S., 2012 - 2022
  • Chart 4-4: CVC Insertion Procedures, U.S., 2012 - 2022
  • Chart 4-5: PICC Insertion Procedures, U.S., 2012 - 2022
  • Chart 4-6: PIVC Insertion Procedures, U.S., 2012 - 2022
  • Chart 4-7: Dialysis Catheter Insertion Procedures, U.S., 2012 - 2022
  • Chart 4-8: Ultrasound Vascular Access Procedures, U.S., 2015

LIST OF FIGURES

LIST OF FIGURES

  • Figure 0-1: Vascular Access Device and Accessories Competitor Market Share Ranking by Segment, U.S.,

2015 (1 of 2)

  • Figure 0-2: Vascular Access Device and Accessories Competitor Market Share Ranking by Segment, U.S.,

2015 (2 of 2)

  • Figure 0-3: Companies Researched in Report, U.S., 2015
  • Figure 0-4: Factors Impacting the Vascular Access Device and Accessories Market by Segment, U.S.
  • Figure 0-5: Recent Events in the Vascular Access Device and Accessories Market, U.S., 2012 - 2015
  • Figure 0-6: Vascular Access Devices & Accessories Markets Covered, U.S., 2015 (1 of 3)
  • Figure 0-7: Vascular Access Devices & Accessories Markets Covered, U.S., 2015 (2 of 3)
  • Figure 0-8: Vascular Access Devices & Accessories Markets Covered, U.S., 2015 (3 of 3)
  • Figure 0-9: Vascular Access Devices & Accessories Procedures Covered, U.S., 2015
  • Figure 0-10: Procedural Codes, U.S., 2015
  • Figure 0-11: Key Report Updates, U.S., 2014 and 2016 (1 of 2)
  • Figure 0-12: Key Report Updates, U.S., 2014 and 2016 (2 of 2)
  • Figure 0-13: Version History
  • Figure 3-1: Digestive Cancer Statistics by Type and Gender, U.S., 2016
  • Figure 3-2: Genital Cancer Statistics by Type and Gender, U.S., 2016
  • Figure 3-3: Breast Cancer Statistics by Type and Gender, U.S., 2016
  • Figure 3-4: Respiratory Cancer Statistics by Type and Gender, U.S., 2016
  • Figure 3-5: Urinary Cancer Statistics by Type and Gender, U.S., 2016
  • Figure 3-6: Skin Cancer Statistics by Type and Gender, U.S., 2016
  • Figure 3-7: Lymphoma Cancer Statistics by Type and Gender, U.S., 2016
  • Figure 3-8: Endocrine Cancer Statistics by Type and Gender, U.S., 2016
  • Figure 3-9: Leukemia Cancer Statistics by Type and Gender, U.S., 2016
  • Figure 3-10: Oral Cavity/Larynx Cancer Statistics by Type and Gender, U.S., 2016
  • Figure 3-11: Myeloma Cancer Statistics by Type and Gender, U.S., 2016
  • Figure 3-12: Brain/Other Nervous System Cancer Statistics by Type and Gender, U.S., 2016
  • Figure 3-13: Soft Tissue (Including Heart) Cancer Statistics by Type and Gender, U.S., 2016 .................... 69 Figure 3-14: Bone and Joint Cancer Statistics by Type and Gender, U.S., 2016
  • Figure 3-15: Eye and Orbit Statistics by Type and Gender, U.S., 2016
  • Figure 3-16: End-Stage Renal Disease Incident Cases, U.S., 1996 - 2015
  • Figure 3-17: End-Stage Renal Disease Incident Cases by Modality, U.S., 1996 - 2015
  • Figure 3-18: End-Stage Renal Disease Incident Cases by Age Group, U.S., 1996 - 2015
  • Figure 3-19: End-Stage Renal Disease Incident Cases Using Home Dialysis by Therapy, U.S., 1996 - 2015

  • Figure 3-20: Vascular Access Use at Hemodialysis Initiation, U.S., 2005 - 2015
  • Figure 3-21: Vascular Access Use During First Year of Hemodialysis, U.S., 2013 - 2014
  • Figure 3-22: Vascular Access Use During First Year of Hemodialysis by Age Group, U.S., 2013 - 2014
  • Figure 3-23: Vascular Access Use During First Year of Hemodialysis by Sex, U.S., 2013 - 2014
  • Figure 3-24: End-Stage Renal Disease Prevalent Case Count, U.S., 1996 - 2015
  • Figure 3-25: End-Stage Renal Disease Prevalent Cases by Modality, U.S., 1996 - 2015
  • Figure 3-26: Prevalent Hemodialysis Patients by Vascular Access Type, U.S., 2003 - 2015
  • Figure 3-27: End-Stage Renal Disease Prevalent Cases by Age Group, U.S., 1996 - 2015
  • Figure 3-28: End-Stage Renal Disease Prevalent Cases Using Home Dialysis by Therapy, U.S., 1996 - 2015

  • Figure 3-29: Diagnosed Diabetes Incidence Count Adults, U.S., 1997 - 2015
  • Figure 3-30: Diagnosed Diabetes Incidence Age-Adjusted Rate per 1000 Adults by State, U.S., 2014 (1 of

2)

  • Figure 3-31: Diagnosed Diabetes Incidence Age-Adjusted Rate per 1000 Adults by State, U.S., 2014 (2 of

2)

  • Figure 3-32: Diagnosed Diabetes Prevalence Count Adults, U.S., 1997 - 2015
  • Figure 3-33: Diagnosed Diabetes Prevalence Count Adults by Medication Status, U.S., 1997 - 2015
  • Figure 3-34: Diagnosed Diabetes Prevalence Age-Adjusted Rate per 100 Adults by State and Age Group,

U.S., 2014 (1 of 2)

  • Figure 3-35: Diagnosed Diabetes Prevalence Age-Adjusted Rate per 100 Adults by State and Age Group,

U.S., 2014 (2 of 2)

  • Figure 3-36: Diagnosed Diabetes Prevalence Age-Adjusted Rate per 100 Adults by State and Gender, U.S.,

2014 (1 of 2)

  • Figure 3-37: Diagnosed Diabetes Prevalence Age-Adjusted Rate per 100 Adults by State and Gender, U.S.,

2014 (2 of 2)

  • Figure 4-1: Procedural Codes, U.S., 2015
  • Figure 4-2: Overall Vascular Access Procedures, U.S., 2012 - 2022 ......................................................... 115 Figure 4-3: Implantable Port Insertion Procedures, U.S., 2012 - 2022
  • Figure 4-4: Port Needle Insertion Procedures, U.S., 2012 - 2022
  • Figure 4-5: CVC Insertion Procedures, U.S., 2012 - 2022
  • Figure 4-6: Mean Number of CVC Kits Used Per Procedure, U.S., 2012 - 2022
  • Figure 4-7: PICC Insertion Procedures, U.S., 2012 - 2022
  • Figure 4-8: PIVC Insertion Procedures, U.S., 2012 - 2022
  • Figure 4-9: Mean Number of PIVCs Used Per Procedure, U.S., 2012 - 2022
  • Figure 4-10: Dialysis Catheter Insertion Procedures, U.S., 2012 - 2022 (1 of 2)
  • Figure 4-11: Dialysis Catheter Insertion Procedures, U.S., 2012 - 2022 (2 of 2)
  • Figure 4-12: Ultrasound Vascular Access Procedures, U.S., 2015
Back to Top